Kaken Pharmaceutical Co (TSE:4521) Price-to-Tangible-Book : 0.99 (As of May. 01, 2024)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-05-01), Kaken Pharmaceutical Co's share price is 円3477.00. Kaken Pharmaceutical Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was 円3,502.84. Hence, Kaken Pharmaceutical Co's Price to Tangible Book Ratio of today is 0.99.

The historical rank and industry rank for Kaken Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

TSE:4521' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.96 Med: 1.76 Max: 5.37
Current: 0.99

During the past 13 years, Kaken Pharmaceutical Co's highest Price to Tangible Book Ratio was 5.37. The lowest was 0.96. And the median was 1.76.

TSE:4521's Price-to-Tangible-Book is ranked better than
84.31% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs TSE:4521: 0.99

A closely related ratio is called PB Ratio. As of today, Kaken Pharmaceutical Co's share price is 円3477.00. Kaken Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was 円3,700.43. Hence, Kaken Pharmaceutical Co's P/B Ratio of today is 0.94.

Kaken Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Kaken Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Price-to-Tangible-Book Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.66

1.53

1.22

1.14

1.07

Kaken Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.11	1.07	1.03	0.98	0.96

Competitive Comparison of Kaken Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaken Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Price-to-Tangible-Book falls into.

Kaken Pharmaceutical Co Price-to-Tangible-Book Calculation

Kaken Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	3477.00	/	3502.835
	=	0.99

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Kaken Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines